| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.084 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |